(Circulation. 1996;94:562-570.)
© 1996 American Heart Association, Inc.
Articles |
Class III Antiarrhythmic Effects of Zatebradine
Time-, State-, Use-, and Voltage-Dependent Block of hKv1.5 Channels
the Institute of Pharmacology and Toxicology, CSIC, School of Medicine, Universidad Complutense, Madrid, Spain, and the Departments of Medicine and Pharmacology, School of Medicine, Vanderbilt University, Nashville, Tenn (D.J.S.).
Correspondence to Carmen Valenzuela, PhD, Institute of Pharmacology and Toxicology, CSIC, School of Medicine, Universidad Complutense, 28040 Madrid, Spain. E-mail carmenva@eucmax.sim.ucm.es.
Background Zatebradine is a bradycardic agent that inhibits the hyperpolarization-activated current (If) in the rabbit sinoatrial node. It also prolongs action potential duration in papillary muscles in guinea pigs and in Purkinje fibers in rabbits. The underlying mechanism by which zatebradine induces this effect has not been explored, but it is likely to involve K+ channel block.
Methods and Results Cloned human cardiac K+ delayed rectifier currents (hKv1.5) were recorded in Ltk- cells transfected with their coding sequence. Zatebradine 10 µmol/L did not modify the initial activation time course of the current but induced a subsequent decline to a lower steady-state current level with a time constant of 109±16 ms. Zatebradine inhibited hKv1.5 with an apparent KD of 1.86±0.14 µmol/L. Block was voltage dependent (electrical distance 
=0.177±0.003) and accumulated in a use-dependent manner during 0.5- and 1-Hz pulse trains because of slower recovery kinetics in the presence of the drug. Zatebradine reduced the tail current amplitude, recorded at -30 mV, and slowed the deactivation time course, which resulted in a "crossover" phenomenon when control and zatebradine tail currents were superimposed.
Conclusions These results indicate that (1) zatebradine is an open-channel blocker of hKv1.5, (2) binding occurs in the internal mouth of the ion pore, (3) unbinding is required before the channel can close, and (4) zatebradine-induced block is use dependent because of slower recovery kinetics in the presence of the drug. These effects may explain the prolongation of the cardiac action potential and could be clinically relevant.
Key Words: heart rate • antiarrhythmia agents • potassium • action potentials
This article has been cited by other articles:
 |
|
 |
|
  G. C. Demontis, C. Gargini, T. G. Paoli, and L. Cervetto Selective Hcn1 Channels Inhibition by Ivabradine in Mouse Rod Photoreceptors Invest. Ophthalmol. Vis. Sci., April 1, 2009; 50(4): 1948 - 1955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Monassier, B. Manoury, C. Bellocq, J. Weissenburger, H. Greney, D. Zimmermann, J.-D. Ehrhardt, P. Jaillon, I. Baro, and P. Bousquet {sigma}2-Receptor Ligand-Mediated Inhibition of Inwardly Rectifying K+ Channels in the Heart J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 341 - 350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Kim, H. S. Ahn, B. H. Choi, H.-J. Jang, M.-J. Kim, D.-J. Rhie, S.-H. Yoon, Y.-H. Jo, M.-S. Kim, K.-W. Sung, et al. Open Channel Block of A-Type, Kv4.3, and Delayed Rectifier K+ Channels, Kv1.3 and Kv3.1, by Sibutramine J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 753 - 762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lagrutta, J. Wang, B. Fermini, and J. J. Salata Novel, Potent Inhibitors of Human Kv1.5 K+ Channels and Ultrarapidly Activating Delayed Rectifier Potassium Current J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1054 - 1063. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-H. Lee, S. M. Jeong, J.-H. Kim, B.-H. Lee, I.-S. Yoon, J.-H. Lee, S.-H. Choi, D.-H. Kim, H. Rhim, S. S. Kim, et al. Characteristics of Ginsenoside Rg3-Mediated Brain Na+ Current Inhibition Mol. Pharmacol., October 1, 2005; 68(4): 1114 - 1126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. H. Choi, J.-A. Park, K.-R. Kim, G.-I. Lee, Y.-T. Lee, H. Choe, S.-H. Ko, M.-H. Kim, Y.-H. Seo, and Y.-G. Kwak Direct block of cloned hKv1.5 channel by cytochalasins, actin-disrupting agents Am J Physiol Cell Physiol, August 1, 2005; 289(2): C425 - C436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Choe, Y.-K. Lee, Y.-T. Lee, H. Choe, S.-H. Ko, C.-U. Joo, M.-H. Kim, G.-S. Kim, J.-S. Eun, J.-H. Kim, et al. Papaverine Blocks hKv1.5 Channel Current and Human Atrial Ultrarapid Delayed Rectifier K+ Currents J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 706 - 712. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Sen, G. Cui, L.-M. Zhou, Y. Sakaguchi, and B. N. Singh Acute Effects of Zatebradine on Cardiac Conduction and Repolarization Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2002; 7(1): 29 - 38. [Abstract] [PDF]
|
|
|
|
|
|
T. González, M. Longobardo, R. Caballero, E. Delpón, J. Tamargo, and C. Valenzuela Effects of Bupivacaine and a Novel Local Anesthetic, IQB-9302, on Human Cardiac K+ Channels J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 573 - 583. [Abstract] [Full Text]
|
|
|
|
|
|
B. H. Choi, J.-S. Choi, S.-W. Jeong, S. J. Hahn, S. H. Yoon, Y.-H. Jo, and M.-S. Kim Direct Block by Bisindolylmaleimide of Rat Kv1.5 Expressed in Chinese Hamster Ovary Cells J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 634 - 640. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Yue, J. L. Feng, Z. Wang, and S. Nattel Effects of ambasilide, quinidine, flecainide and verapamil on ultra-rapid delayed rectifier potassium currents in canine atrial myocytes Cardiovasc Res, April 1, 2000; 46(1): 151 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Caballero, E. Delpon, C. Valenzuela, M. Longobardo, and J. Tamargo Losartan and Its Metabolite E3174 Modify Cardiac Delayed Rectifier K+ Currents Circulation, March 14, 2000; 101(10): 1199 - 1205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Delpon, C. Valenzuela, P. Gay, L. Franqueza, D. J Snyders, and J. Tamargo Block of human cardiac Kv1.5 channels by loratadine: voltage-, time- and use-dependent block at concentrations above therapeutic levels Cardiovasc Res, August 1, 1997; 35(2): 341 - 350. [Abstract] [Full Text] [PDF]
|
|